Balloon Catheter

Videos | Balloon Catheter | November 16, 2016

A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the...

Bard, Lutonix 014 DCB, drug-coated balloon, six-month endpoint, FDA IDE trial
Technology | Drug-Eluting Balloons | September 26, 2016

September 26, 2016 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an...

Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons | September 22, 2016

September 22, 2016 — New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the...

Medtronic, IN.PACT Admiral drug-coated balloon, DCB, FDA approval, in-stent restenosis, ISR
Technology | Drug-Eluting Balloons | September 19, 2016

September 19, 2016 — Medtronic plc announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT...

lithoplasty, lithotripsy for arteries

The Shockwave Medical Lithoplasty system combines a balloon catheter with tiny lithotripsy electrodes that emit pulses to crack and break up calcium in peripheral arteries.

Technology | Peripheral Arterial Disease (PAD) | September 16, 2016

September 16, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance for Shockwave Medical’...

Videos | Peripheral Arterial Disease (PAD) | September 16, 2016

Shockwave Medical’s Lithoplasty System uses ultrasonic waves to treatment calcified plaque in patients with...

VIVA 2016, late breaking trials, cath lab
Feature | Cath Lab | September 14, 2016

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular...

Medtronic, In.Pact Admiral drug coated balloon, DCB, FDA approval, 150 mm length
Technology | Drug-Eluting Balloons | July 18, 2016

July 18, 2016 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT Admiral...

News | Drug-Eluting Balloons | June 03, 2016

June 3, 2016 — Cardionovum GmbH recently announced the completion of enrollment of the RAPID trial. Results will be...

TOBA-BTK study, twelve-month results, SCAI 2016, Tack Endovascular System, critical limb ischemia
News | Peripheral Arterial Disease (PAD) | May 05, 2016

May 5, 2016 — Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon...

NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016

March 28, 2016 — NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The...

PinnacleHealth Cardiovascular Institute, TOBA II study, first patient, Tack Endovascular System, PAD
News | Peripheral Arterial Disease (PAD) | March 22, 2016

March 22, 2016 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II...

Intact Vascular, Tack Endovascular System

The Intact Vascular Tack Endovascular System is designed to spot stent dissections with a short, self-expanding 6 mm long stent that can expand to vessel diameters between 2.5-6 mm, so exact sizing is not needed.

Feature | Peripheral Arterial Disease (PAD) | February 22, 2016 | Dave Fornell

It is estimated that more than 10 million people in the United States are affected by...

TOBA-BTK study, six-month results, LINC 2016, Tack Endovascular System
News | Peripheral Arterial Disease (PAD) | January 29, 2016

January 29, 2016 — Intact Vascular Inc. announced that positive six-month results from its Tack Optimized Balloon...

Medtronic, CE Mark, IN.PACT Admiral DEB, arteriovenous AV access, hemodialysis, end-stage renal disease patients
News | Drug-Eluting Balloons | January 18, 2016

January 18, 2016 — Medtronic plc announced that the IN.PACT Admiral ...

Overlay Init